FDA’s Early Statements on CBD Regulation, Explained
By: Heidi Urness, Attorney at Heidi Urness Law On April 1, 2019, the U.S. Food and Drug Administration (“FDA”) issued yet another “statement” regarding its ever-evolving position with respect to CBD, again offering little to no information, and providing generally no predictability, to business working with – or considering working with – CBD. Many CBD business…
Read more